We are live on
!
Find out more
VP
venBio Partners Portfolio holdings
AUM
$281M
1-Year Est. Return
261.03%
This Fund
S&P 500
This Quarter
Est. Return
-8.23%
1 Year Est. Return
+261.03%
3 Year Est. Return
+648.19%
5 Year Est. Return
+623.84%
10 Year Est. Return
–
AUM
$351M
AUM Growth
-$99.9M
(-22%)
Cap. Flow
-$14.8M
Cap. Flow
% of AUM
-4.21%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
1
Reduced
3
Closed
1
Top Buys
| 1 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
+$3.15M |
Top Sells
| 1 |
CMPI
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
|
+$11.7M |
| 2 |
Harmony Biosciences
HRMY
|
+$4.31M |
| 3 |
ELEV
Elevation Oncology
ELEV
|
+$1.86M |
| 4 |
Pharvaris
PHVS
|
+$34.6K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
ALX Oncology
ALXO
$272M
| $78.5M | 22.34% |
9,699,925
| – | – |
|
|
2
Harmony Biosciences
HRMY
$1.93B
| $70.7M | 20.12% |
1,448,720
-95,764
| -6% | -$4.31M |
|
|
VTYX
3
DELISTED
Ventyx Biosciences
VTYX
| $61.3M | 17.45% |
5,011,536
| – | – |
|
|
4
Pharvaris
PHVS
$2.35B
| $50.9M | 14.48% |
2,301,451
-1,859
| -0.1% | -$34.6K |
|
|
CINC
5
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $40.4M | 11.51% |
2,145,035
+164,329
| +8% | +$3.15M |
|
|
IMPL
6
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $25.7M | 7.32% |
2,759,791
| – | – |
|
|
AKRO
7
DELISTED
Akero Therapeutics
AKRO
| $20.5M | 5.84% |
2,171,664
| – | – |
|
|
ELEV
8
DELISTED
Elevation Oncology
ELEV
| $2.61M | 0.74% |
1,866,339
-741,828
| -28% | -$1.86M |
|
|
VRNA
9
DELISTED
Verona Pharma
VRNA
| $678K | 0.19% |
161,897
| – | – |
|
|
CMPI
10
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| – | – |
-3,673,374
| Closed | -$11.7M |
|
Similar funds
OCWP
FFP
BDA
PHC
OFCM
SA
ACC
NRCM